Edition:
United States

Zeba Siddiqui

5:30am EDT

India to expand access to J&J's TB drug this year

MUMBAI India's top tuberculosis fighter said the government will expand access to Johnson & Johnson's breakthrough TB drug this year, but health experts warn much more needs to be done to eliminate the superbug by 2025.

Apr 11 2017

Mahindra & Mahindra, SsangYong to develop electric SUVs by 2020

MUMBAI Indian automaker Mahindra & Mahindra Ltd and its Korean unit SsangYong Motor Co plan to jointly develop a platform to manufacture electric sport-utility vehicles (SUV) by 2020, the companies said on Tuesday.

Mar 17 2017

Indian drugmakers face squeeze in U.S. healthcare market

MUMBAI India's small and medium-sized generic drugmakers say the threat of tougher rules and higher barriers for outsiders in the U.S. healthcare market will force many to find a niche or focus their expansion efforts on other countries.

Feb 14 2017

Sun Pharma's profits drop as U.S. sales hit by pricing, supply issues

MUMBAI Sun Pharmaceutical Industries, India's largest drugmaker, reported its first fall in quarterly profits in a year on Tuesday, as pricing issues and supply constraints affected sales in the United States, its largest market.

Feb 10 2017

Aurobindo plans second U.S. plant as Trump calls for local production

MUMBAI Indian drugmaker Aurobindo Pharma plans to set up a factory in the United States for injectable products, it said on Friday, days after U.S. President Donald Trump called on pharmaceutical companies to make more drugs locally.

Feb 10 2017

India's Aurobindo eyes U.S. plant amid Trump push on jobs

MUMBAI, Feb 10 Indian drugmaker Aurobindo Pharma said on Friday it was looking to set up a manufacturing facility for injectable products in the United States, days after President Donald Trump called on pharmaceutical companies to make more drugs locally.

Feb 09 2017

Drugmaker Lupin posts strong Q3; warns competition to drag next year

MUMBAI Indian drugmaker Lupin Ltd reported a better-than-expected quarterly profit, helped by higher sales of its diabetes products in the United States, but cautioned growth in the next fiscal year would be muted due to rising competition.

Feb 08 2017

Cipla looks to boost US business as third-quarter profit beats estimates

MUMBAI Indian drugmaker Cipla Ltd's third-quarter profit beat estimates due to higher sales in the United States, and the company said it was looking for licensing deals and acquisitions to build its speciality medicines pipeline in that market.

Dec 27 2016

Serial testers and cursory checks: India's flawed generic drug trials business

HYDERABAD Vasudeva Prakash left his job as a mechanic in Hyderabad three years ago for what he calls a more lucrative career: taking part in clinical trials on generic drugs.

Dec 13 2016

FDA finds quality control problems at Sun Pharma's Halol plant

MUMBAI The U.S. Food and Drug Administration (FDA) has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report obtained by Reuters shows.

More From Around the Web

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary